Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
322 studies found for:    Open Studies | "Carcinoma, Renal Cell"
Show Display Options
Rank Status Study
21 Recruiting Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Conditions: Clear Cell Renal Cell Carcinoma;   Recurrent Renal Cell Carcinoma;   Stage IV Renal Cell Cancer
Interventions: Drug: Pazopanib Hydrochloride;   Other: Pharmacological Study;   Other: Placebo;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
22 Recruiting Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer
Conditions: Head and Neck Squamous Cell Carcinoma;   Metastatic Renal Cell Cancer;   Recurrent Head and Neck Carcinoma;   Recurrent Lung Carcinoma;   Recurrent Renal Cell Carcinoma;   Recurrent Skin Carcinoma;   Stage III Renal Cell Cancer;   Stage IV Lung Cancer;   Stage IV Skin Melanoma
Interventions: Radiation: Radiation Therapy (RT);   Drug: MK-3475
23 Recruiting Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Interventions: Drug: Pazopanib;   Other: Low Fat Diet
24 Recruiting PII SBRT + Microwave Ablation in Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Interventions: Radiation: Stereotactic Body Radiation Therapy (SBRT);   Procedure: Microwave Ablation (MWA)
25 Recruiting Glycosaminoglycan Scores as Predictive Biomarkers in Confined Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Intervention:
26 Recruiting Glycosaminoglycan Scores as Predictive Biomarkers in Advanced Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Intervention:
27 Recruiting Intraoperative Dual-modality Imaging in Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Interventions: Drug: Indium-111-DOTA-Girentuximab-IRDye800CW;   Radiation: SPECT/CT;   Procedure: Intraoperative dual-modality imaging
28 Recruiting Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer
Condition: Metastatic Renal Cell Cancer
Interventions: Drug: RX-0201;   Drug: Everolimus
29 Not yet recruiting Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma;   Kidney Cancer
Interventions: Drug: Durvalumab;   Drug: Tremelimumab
30 Recruiting Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma;   Kidney Cancer
Interventions: Drug: 18F-DCFPyL;   Procedure: PET/CT
31 Recruiting S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Condition: Kidney Cancer
Interventions: Drug: everolimus;   Other: placebo
32 Recruiting Tumor Registry of Advanced Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention:
33 Recruiting Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.
Condition: Carcinoma, Renal Cell
Intervention: Radiation: Stereotactic body radiotherapy
34 Recruiting Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)
Condition: Kidney Cancer
Interventions: Drug: Pazopanib;   Drug: Temsirolimus;   Behavioral: Quality of Life Assessment;   Drug: Benadryl
35 Recruiting Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Intervention: Drug: Pazopanib
36 Recruiting Kidney Cancer DNA Registry
Condition: Renal Cancer
Interventions: Other: salvia for germline DNA;   Behavioral: the Kidney Cancer Questionnaire;   Behavioral: Family History Questionnaire (when applicable)
37 Recruiting Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
Condition: Kidney Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: sunitinib malate
38 Unknown  Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer
Condition: Kidney Cancer
Intervention: Drug: sunitinib malate
39 Not yet recruiting REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT
Conditions: Renal Cell Carcinoma;   Kidney Cancer
Intervention: Drug: Iodine (124I) Girentuximab
40 Recruiting Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
Conditions: Renal Cancer;   Chromophobe Renal Cell Carcinoma;   Birt-Hogg-Dube Syndrome
Intervention: Drug: Everolimus

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years